GeoZentrum Nordbayern - Mineralogy, Friedrich-Alexander-University of Erlangen-Nuernberg, Schlossgarten 5a, 91054 Erlangen, Germany.
Department for Functional Materials in Medicine and Dentistry, University of Wuerzburg, Pleicherwall 2, 97070 Würzburg, Germany.
Acta Biomater. 2018 Oct 15;80:378-389. doi: 10.1016/j.actbio.2018.09.002. Epub 2018 Sep 6.
Calcium phosphate cements composed of β-tricalcium phosphate (β-TCP) and phosphoric acid were modified by addition of 5, 10, 12.5, 15 and 20 wt% phytic acid (IP6) related to the β-TCP content and compared to a reference containing 0.5 M citric acid monohydrate solution as setting regulator. The hydration reaction of these cements was investigated by isothermal calorimetry and in-situ X-ray diffraction at 23 °C and 37 °C. The cements were further characterized with respect to their injectability, rheology, zeta potential and time-resolved compressive strength development. Injectability was strongly improved by IP6 addition, while the maximum effect was already reached by the addition of 5 wt% IP6. This could be clearly related to an increase of the negative zeta potential leading to a mutual repulsion of cement particles. A further increase of the IP6 content had a detrimental effect on initial paste viscosity and shifted the gelation point to earlier time points. IP6 was further proven to act as a retarder for the cement setting reaction, whereas the effect was stronger for higher IP6 concentrations. Additionally, IP6 favoured the formation of monetite instead of brushite and a better mechanical performance compared to the IP6 free reference cement. STATEMENT OF SIGNIFICANCE: Calcium phosphate cements (CPCs) are clinically applied for bone repair due to their excellent biocompatibility and bone regeneration capacity. A deep understanding of the setting mechanism is the prerequisite for the targeted fabrication and application of such bone cements, whereas setting characteristics are usually adjusted by additives. Here, novel injectable CPC formulations were developed by modifying a cement composed of β-tricalcium phosphate and phosphoric acid with phytic acid (IP6). A detailed investigation of the setting mechanism of the IP6 modified CPCs is provided, which demonstrated the effectiveness of IP6 as setting regulator to adjust the reaction time and kind of setting product. Additionally, the high surface charge of cement particles after IP6 addition was effective in dispersing cement particles leading to low viscous cement pastes, which can be directly applied through a syringe for minimal invasive surgery.
由β-磷酸三钙 (β-TCP) 和磷酸组成的磷酸钙水泥通过添加 5wt%、10wt%、12.5wt%、15wt%和 20wt%植酸 (IP6) 进行改性,添加量相对于 β-TCP 含量,与含有 0.5M 一水柠檬酸作为凝固调节剂的参比水泥进行对比。通过等温量热法和 23°C 和 37°C 下的原位 X 射线衍射研究了这些水泥的水化反应。进一步对这些水泥的可注射性、流变学、ζ 电位和时变抗压强度发展进行了表征。通过添加 IP6 可显著改善可注射性,而添加 5wt% IP6 即可达到最大效果。这显然可以归因于负 ζ 电位的增加,导致水泥颗粒相互排斥。进一步增加 IP6 的含量会对初始膏体粘度产生不利影响,并将胶凝点提前到更早的时间点。进一步证明 IP6 是水泥凝固反应的缓凝剂,而随着 IP6 浓度的增加,其效果更强。此外,IP6 有利于单水磷酸氢钙的形成而不是二水磷酸氢钙的形成,与不含 IP6 的参考水泥相比,具有更好的机械性能。
磷酸钙水泥 (CPCs) 由于其出色的生物相容性和骨再生能力,在临床上被用于骨修复。深入了解凝固机制是针对此类骨水泥进行靶向制造和应用的前提条件,而凝固特性通常通过添加剂进行调整。在这里,通过用植酸 (IP6) 改性由 β-磷酸三钙和磷酸组成的水泥,开发了新型可注射 CPC 配方。详细研究了 IP6 改性 CPC 的凝固机制,证明了 IP6 作为凝固调节剂来调节反应时间和凝固产物类型的有效性。此外,添加 IP6 后水泥颗粒的高表面电荷有效地分散了水泥颗粒,导致低粘性的水泥糊,可直接通过注射器用于微创外科手术。